Neochem Bio Solutions Ltd
- Market Cap ₹ 168 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 21.8
- Book Value ₹
- Dividend Yield %
- ROCE 27.2 %
- ROE 48.4 %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 48.19 | 61.15 | 84.17 | |
| 43.95 | 55.16 | 71.05 | |
| Operating Profit | 4.24 | 5.99 | 13.12 |
| OPM % | 8.80% | 9.80% | 15.59% |
| 0.60 | 0.86 | 1.98 | |
| Interest | 2.10 | 2.96 | 3.51 |
| Depreciation | 1.22 | 1.22 | 1.33 |
| Profit before tax | 1.52 | 2.67 | 10.26 |
| Tax % | 28.95% | 32.58% | 24.46% |
| 1.07 | 1.80 | 7.75 | |
| EPS in Rs | 1.97 | 2.70 | 11.61 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 330% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 48% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 5.43 | 6.68 | 6.68 |
| Reserves | 2.63 | 5.33 | 13.08 |
| 26.24 | 33.32 | 35.63 | |
| 16.31 | 18.73 | 23.50 | |
| Total Liabilities | 50.61 | 64.06 | 78.89 |
| 14.67 | 18.81 | 18.67 | |
| CWIP | 0.04 | 0.03 | 0.06 |
| Investments | 0.00 | 0.00 | 0.00 |
| 35.90 | 45.22 | 60.16 | |
| Total Assets | 50.61 | 64.06 | 78.89 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 109.22 | 102.90 | 109.63 |
| Inventory Days | 174.77 | 172.24 | 157.02 |
| Days Payable | 156.98 | 133.36 | 107.72 |
| Cash Conversion Cycle | 127.01 | 141.78 | 158.93 |
| Working Capital Days | 20.53 | 32.29 | 39.33 |
| ROCE % | 14.09% | 27.20% |
Documents
Annual reports
No data available.